Working... Menu
Trial record 5 of 11 for:    GS-9451 OR Vedroprevir

GS 5885 Administered Concomitantly With GS-9451, Tegobuvir and Ribavirin (RBV) in Chronic Genotype 1 Hepatitis C Virus (HCV) Infection

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01353248
Recruitment Status : Completed
First Posted : May 13, 2011
Last Update Posted : December 20, 2013
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2012
  Actual Study Completion Date : March 2013
  Certification/Extension First Submitted : November 26, 2013